PMID- 37317584
OWN - NLM
STAT- MEDLINE
DCOM- 20231115
LR  - 20231115
IS  - 1879-3479 (Electronic)
IS  - 0020-7292 (Linking)
VI  - 163
IP  - 3
DP  - 2023 Dec
TI  - Comparison of Diabetes in Pregnancy Study Group India (DIPSI) and WHO criteria 
      for diagnosis of gestational diabetes by assessment of fetomaternal outcomes.
PG  - 948-955
LID - 10.1002/ijgo.14921 [doi]
AB  - OBJECTIVE: To evaluate fetomaternal outcomes in women who are normoglycemic by 
      Diabetes in Pregnancy Study Group India (DIPSI) but have gestational diabetes 
      mellitus (GDM) by WHO criteria versus those who are normoglycemic by both DIPSI 
      and WHO criteria. METHODS: This was a prospective, cohort study. A total of 635 
      women participated. They underwent a 2-h non-fasting oral glucose tolerance test 
      (OGTT) and results were interpreted by DIPSI. Out of 635 women, 52 were lost to 
      follow up and 33 were diagnosed as GDM by DIPSI and excluded from the study. The 
      remaining 550 women, after 72 h from the first test, underwent a 75-g 
      fasting-OGTT and results were interpreted using WHO 2013 criteria. Results of the 
      second test were blinded till delivery. The 550 women were followed for 
      fetomaternal outcomes. Participants with normal DIPSI and normal WHO 2013 OGTT 
      were labeled group 1. Participants with normal DIPSI but abnormal WHO 2013 OGTT 
      were labeled group 2. Fetomaternal outcomes were compared between these groups. 
      RESULTS: Occurrence of GDM by DIPSI was 5.1%, by WHO 2013 criteria it was 10.5%. 
      Composite fetomaternal outcomes occurred more commonly in women with a normal 
      DIPSI but an abnormal WHO 2013 test. Out of 550 women, 492 had normal DIPSI and 
      normal WHO 2013 test. Out of this 492, 116 (23.6%) women had adverse fetomaternal 
      outcomes. Fifty-eight women out of 550 had a normal DIPSI but an abnormal WHO 
      2013 test. Thirty-seven (63.8%) women out of 58 had adverse fetomaternal 
      outcomes. We found statistically significant association between adverse 
      fetomaternal outcome and GDM by WHO 2013 test (with normal DIPSI test). 
      CONCLUSION: WHO 2013 has superior diagnostic value compared with DIPSI criteria 
      for diagnosis of GDM.
CI  - (c) 2023 International Federation of Gynecology and Obstetrics.
FAU - Raghav, Mansvi
AU  - Raghav M
AD  - Department of Obstetrics and Gynecology, V.M.M.C & Safdarjung Hospital, New 
      Delhi, India.
FAU - Suri, Jyotsna
AU  - Suri J
AUID- ORCID: 0000-0002-7838-3238
AD  - Department of Obstetrics and Gynecology, V.M.M.C & Safdarjung Hospital, New 
      Delhi, India.
FAU - Rani, Anita
AU  - Rani A
AD  - Department of Biochemistry, V.M.M.C & Safdarjung Hospital, New Delhi, India.
FAU - Debata, Pradeep
AU  - Debata P
AD  - Department of Pediatrics, V.M.M.C & Safdarjung Hospital, New Delhi, India.
FAU - Bachani, Sumitra
AU  - Bachani S
AD  - Department of Obstetrics and Gynecology, V.M.M.C & Safdarjung Hospital, New 
      Delhi, India.
LA  - eng
PT  - Journal Article
DEP - 20230614
PL  - United States
TA  - Int J Gynaecol Obstet
JT  - International journal of gynaecology and obstetrics: the official organ of the 
      International Federation of Gynaecology and Obstetrics
JID - 0210174
RN  - 0 (Blood Glucose)
SB  - IM
MH  - Pregnancy
MH  - Female
MH  - Humans
MH  - Male
MH  - *Diabetes, Gestational/diagnosis/epidemiology
MH  - Cohort Studies
MH  - Prospective Studies
MH  - *Pregnancy in Diabetics
MH  - India/epidemiology
MH  - World Health Organization
MH  - Pregnancy Outcome
MH  - Blood Glucose
OTO - NOTNLM
OT  - Diabetes in Pregnancy Study Group India
OT  - International Association of Diabetes in Pregnancy Study Group
OT  - WHO 2013 criteria
OT  - adverse pregnancy outcomes
OT  - fetomaternal outcomes
OT  - gestational diabetes mellitus
OT  - hyperglycemia and adverse pregnancy outcome study
OT  - screening
EDAT- 2023/06/15 06:42
MHDA- 2023/11/15 06:42
CRDT- 2023/06/15 03:49
PHST- 2023/05/22 00:00 [revised]
PHST- 2023/03/18 00:00 [received]
PHST- 2023/05/23 00:00 [accepted]
PHST- 2023/11/15 06:42 [medline]
PHST- 2023/06/15 06:42 [pubmed]
PHST- 2023/06/15 03:49 [entrez]
AID - 10.1002/ijgo.14921 [doi]
PST - ppublish
SO  - Int J Gynaecol Obstet. 2023 Dec;163(3):948-955. doi: 10.1002/ijgo.14921. Epub 
      2023 Jun 14.